Plasma Donors in the Southwestern United States Positively Contribute to the Diverse Therapeutic Antibody Profile of Immune Globulin Products
暂无分享,去创建一个
[1] G. Xia,et al. Hepatitis Awareness Month and Testing Day — May 2019 , 2019, Morbidity and Mortality Weekly Report.
[2] P. Vandeberg,et al. Measles antibody trough levels after treatment with immunoglobulin products and predicted levels assuming lower measles antibody specifications , 2018, Transfusion.
[3] Ivan K. Chinn,et al. Update on the use of immunoglobulin in human disease: A review of evidence , 2017, The Journal of allergy and clinical immunology.
[4] M. Costafreda,et al. Evaluation of Potencies of Immune Globulin Products Against Hepatitis A , 2017, JAMA internal medicine.
[5] Noele P. Nelson,et al. Progress Toward Eliminating Hepatitis A Disease in the United States. , 2016, MMWR supplements.
[6] W. Bellini,et al. Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010 , 2015, Open forum infectious diseases.
[7] C. Cunningham-Rundles,et al. An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. , 2014, Immunotherapy.
[8] W. Bellini,et al. Measles — United States, January 1–May 23, 2014 , 2014, MMWR. Morbidity and mortality weekly report.
[9] C. Stenland,et al. Ensuring the Biologic Safety of Plasma-Derived Therapeutic Proteins , 2012, BioDrugs.
[10] R. Jacobson,et al. The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines? , 2012, Vaccine.
[11] B. Bell,et al. Seroprevalence of Hepatitis A Virus Antibodies in the U.S.: Results from the National Health and Nutrition Examination Survey , 2011, Public health reports.
[12] M. Eibl. History of immunoglobulin replacement. , 2008, Immunology and allergy clinics of North America.
[13] D. Niebuhr,et al. Rising hepatitis A immunity in U.S. military recruits. , 2007, Military medicine.
[14] D. Scott,et al. Measles-virus-neutralizing antibodies in intravenous immunoglobulins. , 2006, The Journal of infectious diseases.
[15] Anthony Fiore,et al. Hepatitis A in the era of vaccination. , 2006, Epidemiologic reviews.
[16] B. Bell,et al. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[17] J. Orange,et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. , 2006, The Journal of allergy and clinical immunology.
[18] B. Bell,et al. Incidence of hepatitis A in the United States in the era of vaccination. , 2005, JAMA.
[19] V. Hemming. Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases , 2001, Clinical Diagnostic Laboratory Immunology.
[20] T. Doyle,et al. Infectious disease morbidity in the US region bordering Mexico, 1990-1998. , 2000, The Journal of infectious diseases.
[21] E. Tabor. The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1 , 1999, Transfusion.
[22] H. Rotman,et al. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization , 1993, Journal of medical virology.
[23] R. Snow,et al. Review of the Evidence. , 1964, Science.
[24] J. Modrof,et al. Hepatitis A virus antibodies in immunoglobulin preparations. , 2010, The Journal of allergy and clinical immunology.
[25] M. Alter,et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[26] Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[27] Ji Jin,et al. Measles--United States. , 1982, MMWR. Morbidity and mortality weekly report.